Relation of diabetes to mild cognitive impairment.

BACKGROUND Type 2 diabetes mellitus is an important risk factor for Alzheimer disease and is more prevalent in elderly minority persons compared with non-Hispanic white persons. OBJECTIVE To determine whether diabetes is related to a higher risk of mild cognitive impairment (MCI), a transitional stage between normal cognition and Alzheimer disease, in a multiethnic cohort with a high prevalence of diabetes. DESIGN Longitudinal cohort study. SETTING Northern Manhattan in New York, NY. PARTICIPANTS We studied persons without prevalent MCI or dementia at baseline and with at least 1 follow-up interval. Of 1772 participants with a complete neuropsychological evaluation, 339 (19.1%) were excluded because of prevalent dementia, 304 were excluded because of prevalent MCI (17.2%), and 211 were excluded because of loss to follow-up (11.9%), resulting in a final sample of 918 participants for longitudinal analyses. MAIN OUTCOME MEASURES We related diabetes defined by self-report to incident all-cause MCI, amnestic MCI, and nonamnestic MCI. We conducted multivariate analyses with proportional hazards regression adjusting for age, sex, years of education, ethnic group, apolipoprotein E (APOE) epsilon4 allele, hypertension, low-density lipoprotein level, current smoking, heart disease, and stroke. RESULTS A total of 334 persons had incident MCI, 160 (47.9%) had amnestic MCI, and 174 (52.1%) had nonamnestic MCI. Diabetes was related to a significantly higher risk of all-cause MCI and amnestic MCI after adjustment for all covariates. Diabetes was also related to a higher risk of nonamnestic MCI, but this association was appreciably attenuated after adjustment for socioeconomic variables and vascular risk factors. The risk of MCI attributable to diabetes was 8.8% for the whole sample and was higher for African American persons (8.4%) and Hispanic persons (11.0%) compared with non-Hispanic white persons (4.6%), reflecting the higher prevalence of diabetes in minority populations in the United States. CONCLUSION Diabetes is related to a higher risk of amnestic MCI in a population with a high prevalence of this disorder.

[1]  R. Mayeux,et al.  Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. , 2005, Archives of neurology.

[2]  T. Beach,et al.  Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center , 2005, Neurology.

[3]  L S Honig,et al.  Aggregation of vascular risk factors and risk of incident Alzheimer disease , 2005, Neurology.

[4]  R. Mayeux,et al.  Hyperinsulinemia and risk of Alzheimer disease , 2004, Neurology.

[5]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[6]  R. Mayeux,et al.  Cardiovascular risk factors and Alzheimer’s disease , 2004, Current atherosclerosis reports.

[7]  M. Smith,et al.  Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link , 1996, Diabetologia.

[8]  R. Mayeux,et al.  Stroke and the risk of Alzheimer disease. , 2003, Archives of neurology.

[9]  D. Loewenstein,et al.  Mild cognitive impairment , 2003, Neurology.

[10]  Yaakov Stern,et al.  Cognitive Reserve and Lifestyle , 2003, Journal of clinical and experimental neuropsychology.

[11]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[12]  Matthew P. Frosch,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Selkoe,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[15]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[16]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[17]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[18]  R. Costa,et al.  Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan , 2001, Neurology.

[19]  T. Aitman.  Insulin Resistance: The Metabolic Syndrome X , 2000 .

[20]  D. Selkoe,et al.  The origins of Alzheimer disease: a is for amyloid. , 2000, JAMA.

[21]  T. Harris,et al.  Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance , 1999, Neurology.

[22]  L. Hersh,et al.  Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.

[23]  M. Harris,et al.  Diabetes in America: Epidemiology and Scope of the Problem , 1998, Diabetes Care.

[24]  Z. Makita,et al.  Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. , 1998, The American journal of pathology.

[25]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[26]  K. Marder,et al.  The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .

[27]  A. Ott.  Risk of dementia: The Rotterdam Study , 1997 .

[28]  E. Kokmen,et al.  Risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997, American journal of epidemiology.

[29]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[30]  A. Hofman,et al.  Association of diabetes mellitus and dementia: The Rotterdam Study , 1996, Diabetologia.

[31]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[32]  R. Mayeux,et al.  Clinical determinants of dememtia related to stroke , 1993, Annals of neurology.

[33]  R. Mayeux,et al.  Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. , 1992, Archives of neurology.

[34]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[35]  H. A. Kahn,et al.  Statistical Methods in Epidemiology , 1989 .

[36]  E. Kaplan,et al.  The Boston naming test , 2001 .

[37]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[38]  W. Grove.  Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[39]  M. Lopes-Virella,et al.  Cholesterol determination in high-density lipoproteins separated by three different methods. , 1977, Clinical chemistry.

[40]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[41]  HERMAN BUSCHKE,et al.  Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.

[42]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[43]  Martha Taylor Sarno,et al.  Assessment of Aphasia and Related Disorders , 1973 .

[44]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[45]  박귀태,et al.  A Type 2 Diabetes–Associated Functional Regulatory Variant in a Pancreatic Islet Enhancer at the ADCY5 Locus , 2017, Diabetes.